Loading organizations...
Spine Wave has raised $100.0M across 3 funding rounds.
Key people at Spine Wave.
Spine Wave has raised $100.0M in total across 3 funding rounds.
Spine Wave is dedicated to developing innovative technologies that assist physicians in treating spinal disorders and improving patients' lives through a broad portfolio of expandable and less invasive surgical solutions.
Spine Wave has raised $100.0M in total across 3 funding rounds.
Spine Wave's investors include Jazz Venture Partners, Osage University Partners, Pioneer Fund, Questa Capital.
Spine Wave has raised $100.0M across 3 funding rounds. Most recently, it raised $18.0M Series E in February 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 1, 2011 | $18M Series E | — | JAZZ Venture Partners, Osage University Partners, Pioneer Fund, Questa Capital | Announced |
| Apr 1, 2007 | $45M Series D | — | Questa Capital | Announced |
| Feb 1, 2006 | $37M Series C | — | Questa Capital | Announced |
Spine Wave is a medical technology company specializing in innovative devices for treating spinal disorders, focusing on expandable and less-invasive surgical solutions for spine surgeons.[1][2][4] It develops and commercializes products like expandable interbody devices, pedicle screw systems, cervical spacers, and graft delivery systems to address spinal fusion, vertebral body replacement, and nucleus augmentation, serving surgeons and patients to restore spinal function and enable pain-free lives.[2][3][4][5] The company has demonstrated growth through a robust product pipeline driven by surgeon input, with a broad portfolio including StaXx XD, Sniper Spine System, CapSure PS3, and newer launches like Salvo Spine System and Leva Interbody Device, positioning it as a leader in the fast-growing spinal market.[3][5]
Spine Wave was founded in February 2001 by Mark LoGuidice and John Pafford, former executives at Sofamor Danek, to commercialize proprietary injectable spinal nucleus technology.[1][3] Early momentum came from a 2002 Series A financing and acquisition of VERTx, targeting vertebral compression fractures and spinal fusion markets, followed by a $45 million Series D round in April 2007.[3] Headquartered in Shelton, Connecticut, the company evolved from nucleus-focused innovations to a comprehensive portfolio of clinical solutions for large spinal segments, building on real-world surgical challenges.[3][4]
Spine Wave rides the trend toward minimally invasive spine surgery, capitalizing on rising demand for efficient, patient-friendly solutions amid an aging population and expanding spinal disorder treatments.[1][2][4] Timing aligns with market growth in vertebral compression fractures and fusion segments, where less-invasive tech reduces recovery times and complications.[3] Favorable forces include healthcare innovation pressures and medtech startups disrupting traditional devices, with Spine Wave influencing the ecosystem through surgeon-focused advancements and a competitive U.S. presence via estimated sales data.[4][5]
Spine Wave is poised to expand its leadership in expandable technologies, with pipeline products and recent launches like Salvo expansions signaling sustained innovation.[5] Trends in bioactive grafts (e.g., Tornado Matrix) and modular systems will shape its path, potentially boosting adoption amid minimally invasive spine surgery growth.[2][5] Its influence may grow through further IP commercialization and market penetration, solidifying its role as a key innovator in restoring spinal health.[1] This builds on its founding commitment to high-quality, differentiated devices for real surgical needs.[2]
Key people at Spine Wave.
